Literature DB >> 12452620

Radical prostatectomy for high grade prostatic intraepithelial neoplasia.

R Woderich1, J McLoughlin, S Deen.   

Abstract

High Grade Prostatic Intraepithelial Neoplasia (HGPIN) has been recognized as the most likely precursor of invasive carcinoma of the prostate. Close surveillance and follow-up are indicated if subsequent procedures fail to identify carcinoma. There is still considerable controversy about the natural history of high grade PIN and most authors agree that its identification should not influence or dictate therapeutic decisions. We performed a prophylactic radical prostatectomy in such a case which has not been reported in the world literature.

Entities:  

Mesh:

Year:  2001        PMID: 12452620     DOI: 10.1023/a:1020504832002

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  5 in total

Review 1.  Prophylactic mastectomy and inherited predisposition to breast carcinoma.

Authors:  K S Hughes; M Z Papa; T Whitney; R McLellan
Journal:  Cancer       Date:  1999-12-01       Impact factor: 6.860

Review 2.  Progression of prostatic intraepithelial neoplasia to early invasive adenocarcinoma.

Authors:  D G Bostwick
Journal:  Eur Urol       Date:  1996       Impact factor: 20.096

Review 3.  Clinical management of familial adenomatous polyposis.

Authors:  D G Jagelman
Journal:  Cancer Surv       Date:  1989

4.  Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: predictive accuracy in needle biopsies.

Authors:  D Davidson; D G Bostwick; J Qian; P C Wollan; J E Oesterling; R A Rudders; M Siroky; M Stilmant
Journal:  J Urol       Date:  1995-10       Impact factor: 7.450

5.  Do prostate specific antigen and prostate specific antigen density enhance the detection of prostate carcinoma after initial diagnosis of prostatic intraepithelial neoplasia without concurrent carcinoma?

Authors:  G Raviv; A R Zlotta; T h Janssen; F Descamps; J P Vanegas; A Verhest; C C Schulman
Journal:  Cancer       Date:  1996-05-15       Impact factor: 6.860

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.